Smooth muscle α actin is specifically required for the maintenance of lactation  by Weymouth, Nate et al.
Developmental Biology 363 (2012) 1–14
Contents lists available at SciVerse ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r .com/deve lopmenta lb io logyFrom the Society for Developmental Biology
Smooth muscle α actin is speciﬁcally required for the maintenance of lactation
Nate Weymouth, Zengdun Shi, Don C. Rockey ⁎
University of Texas Southwestern Medical Center, Dallas, TX, USA⁎ Corresponding author at: University of Texas South
Harry Hines Blvd., Dallas, TX 75390-8887, USA.
E-mail address: don.rockey@utsouthwestern.edu (D
0012-1606/$ – see front matter © 2011 Elsevier Inc. All
doi:10.1016/j.ydbio.2011.11.002a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 16 May 2011
Revised 3 November 2011
Accepted 4 November 2011
Available online 12 November 2011
Keywords:
Smooth muscle α-actin
Mammary gland
Myoepithelial cell
Lactation
MouseSmooth muscle α-actin (Acta2) is one of six highly conserved mammalian actin isoforms that appear to ex-
hibit functional redundancy. Nonetheless, we have postulated a speciﬁc functional role for the smooth mus-
cle speciﬁc isoform. Here, we show that Acta2 deﬁcient mice have a remarkable mammary phenotype such
that dams lacking Acta2 are unable to nurse their offspring effectively. The phenotype was rescued in cross
fostering experiments with wild type mice, excluding a developmental defect in Acta2 null pups. The mech-
anism for the underlying phenotype is due to myoepithelial dysfunction postpartum resulting in precocious
involution. Further, we demonstrate a speciﬁc defect in myoepithelial cell contractility in Acta2 null mamma-
ry glands, despite normal expression of cytoplasmic actins. We conclude that Acta2 speciﬁcally mediates
myoepithelial cell contraction during lactation and that this actin isoform therefore exhibits functional
speciﬁcity.
© 2011 Elsevier Inc. All rights reserved.Introduction
Actin is a highly abundant structural protein of the cytoskeleton
found in eukaryotic cells, which serves critical roles in cell motility
and muscle contraction. At least six actin isoforms have been identi-
ﬁed in eukaryotic cells (Vandekerckhove and Weber, 1978), which
are products of six different genes (Herman, 1993; Miwa et al.,
1991; Rubenstein, 1990). Although the isoactins are expressed in spa-
tial, temporal, and tissue speciﬁc patterns, they exhibit remarkable
amino acid identity. Two “nonmuscle” actins, cytoplasmic β and γ-
actins, are thought to be present in all cells. The other four actin iso-
forms, which include skeletal, cardiac, vascular, and enteric actins,
are typically found in speciﬁc adult muscle types, although they are
also present in specialized cell types. The muscle speciﬁc actins differ
from the nonmuscle cytoplasmic actins at less than 10% of the total
375 amino acid residues that make up the primary sequence, while
the muscle speciﬁc isoforms differ from each by only a few residues
(McHugh et al., 1991; Miwa et al., 1991).
The remarkable conservation of actin isoforms suggests that actin
isoforms are functionally similar. Several cell-based experiments sup-
port this conclusion (Gunning et al., 1984; Rubenstein and Spudich,
1977; von Arx et al., 1995). For example, when the cytoplasmic β-
actin isoform was over expressed in C2 myoblasts, it caused an in-
crease in cellular surface area while over expression of γ-isoform
caused cells to roundup (Lloyd et al., 1992). Myogenic cells have
been shown to regulate the expression of speciﬁc actin isoforms in a
manner that alters the expression of cytoplasmic actins to musclewestern Medical Center, 5323
.C. Rockey).
rights reserved.isoforms. Quiescent aortic smooth muscle cells express a signiﬁcant
amount of Acta2. However, when these cultured cells begin to prolif-
erate and migrate, they increase the expression of cytoplasmic actins,
which suggests a level of functional speciﬁcity (Barja et al., 1986).
Considerable debate exists about the conclusiveness of such cell
culture-based studies and raises questions about the function of
actin isoforms (Bulinski, 2006).
Phenotypic analysis of actin isoform deﬁcient mice provides some
evidence supporting the concept that actin isoforms mediate speciﬁc
functions. Mice deﬁcient in skeletal muscle α-actin (Acta1) died early
in neonatal development due to defects in skeletal muscle growth
and/or function (Crawford et al., 2002). Deletion of cardiac muscle
α-actin (Actc1) led to defects in myocardial contractility, sarcomeric
organization, and an apparent compensatory increase in Acta1
mRNA as well as Acta2 protein levels in the hearts of null mice
(Kumar et al., 1997). A hypomorphic allele in cytoplasmic β-actin
(Actb) proved to be embryonic lethal prior to the beginning of muscle
development (Shawlot et al., 1998). A conditional allele for cytoplas-
mic γ-actin (Actg1) in which this actin was deleted only from muscle
tissue was characterized by a progressive myopathy (Sonnemann et
al., 2006) without an apparent change in isoactin expression. Thus,
all actin isoform mouse knockouts, except smooth muscle γ-actin
(Actg2), have been reported and have yielded data suggesting some ele-
ment of isoform speciﬁcity, as well as overlapping cellular functions
(Perrin and Ervasti, 2010).
Here, we have hypothesized Acta2, while exhibiting a high degree
of identity to the other actin isoforms, exhibits functional speciﬁcity.
We further postulated that such functional speciﬁcity was likely to
be observed in a tissue speciﬁc fashion and/or under stress condi-
tions. Given Acta2's implied role in myoﬁbroblast contraction
(Rockey et al., 1993) and the predominance of this isoform in
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an essential function in myoepithelial contraction and the mainte-
nance of lactation. We discovered that Acta2 deﬁcient (−/−) dams
failed to nurse their pups effectively and that the mechanism under-
lying this phenotype is linked to hypocontractility of myoepithelial
cells due to a lack of Acta2.
Materials and methods
Antibodies
Primary antibodies used were as follows: anti-Acta2 Cy3 (1A4;
Part# C6198; Sigma, St Louis, MO), anti-keratin 14 (Part# PRB-
155P; Covance, Berkeley, CA), anti-troma1 or anti-keratin 8 (Part#
TROMA-1; University of Iowa Hybridoma Bank), anti-vimentin
(Part# AB 5733; Chemicon, Temecula, CA), anti-GFAP (6F2; Part#
MO761; Dako, Carpinteria, CA), anti-SM22α (Polyclonal antibody #
1387-4; a gift from Dr. M. Parmacek), anti-total actin (C4; Part#
MAB1501; Chemicon), anti-β-actin ((Actb); AC-15; Part# A1978;
Sigma), anti- smooth muscle α-actin ((Acta2); 1A4; Part# A5228;
Sigma), anti-smooth muscle γ-actin ((Actg2); B4;(Lessard, 1988)),
anti-cytoplasmic γ-actin ((Actg1); monoclonal- (Dugina et al.,
2009); polyclonal- (Hanft et al., 2006)), anti-cardiac and skeletal α-
actin ((Actc1 and Acta1); 5C5; Part# A2172; Sigma), anti-muscle
actins (HUC 1-1; Part# 691391; MP Biomedicals, Solon, OH), anti-
myosin sarcomere (MF20; Part# MF20; University of Iowa
Hybridoma Bank), anti-myosin cytoplasmic non-muscle (CMII 23;
Part# CMII 23; University of Iowa Hybridoma Bank), anti-myosin
smooth muscle (Part# BT-562; Biomedical Technologies, Stoughton,
MA) and anti-GAPDH (1D4; Part# MMS-580S; Covance, Princeton,
NJ). Secondary antibodies used were as follows: Donkey anti-mouse
Cy2, Donkey anti rat Cy5, Donkey anti mouse Cy2 (Molecular Probes,
Carlsbad, CA), and Donkey anti mouse IgG HRP (Jackson Immunore-
search; West Grove, PA). Milk antibodies: anti-rat β casein antibody
(a gift from Dr. C. Kaetzel) and anti-mouse speciﬁc milk proteins
(anti α-casein, β-casein and WAP; Part# YNRMTM; Accurate Chemi-
cal, Westbury, NY). Nuclear stains included BOPRO (Molecular
Probes) and DAPI (Vector Labs, Burlingame, CA).
Mice husbandry, maternal care, and genotyping
The targeted disruption of the Acta2 gene by homologous recom-
bination has been previously described (Schildmeyer et al., 2000).
Using a PCR screen, the genotype of litters from heterozygous matings
revealed normal Mendelian ratios, as previously reported
(Schildmeyer et al., 2000).
In rodents, maternal behavior involves a complex set of activities,
which include nest building and repair, snifﬁng of pups, pup retrieval,
licking, grooming as well as blanket nursing. Indeed, several genes
have been shown to be essential for maternal behavior. We carefully
monitored Acta2−/− dams for a full range of maternal behavior as
previously described (Yeo and Keverne, 1986) and found that these
mice exhibited entirely normal mother–pup interactions.
Acta2−/− mice were maintained on an out bred (BalbC/129/SvJ)
genetic background. Acta2 mice were backcrossed to a BalbC strain.
All animal care and experiments were carried out in accordance
with NIH guidelines and approved by the local Animal Care and Use
Committee. All mice were housed in cages with ﬁlter top cages and
subjected to 12L:12D cycles. For the purposes of breeding and time
pregnancies, 10–14 week old females were placed with stud males,
checked daily for copulation plugs, and weighted during gestation
in order to determine the timing of pregnancy. If a copulation plug
was observed, the female was housed individually and given nesting
materials. The presence of a copulation plug was designated as day
0.5 of pregnancy. Acta2+/+ females (BalbC/129/SvJ and BalbC)
birthed between 20 and 21 days after the observation of thecopulation plug. However, 10% of Acta2−/− pregnant females
(BalbC/129/SvJ and BalbC) exhibited a failure or delay of parturition
(by about 5 days). Thus, monitoring the presence of copulation
plugs and recording weights of pregnant females were important to
determine the correct timing of mammary gland development.
Cross fostering and administration of oxytocin
Acta2+/+ and −/− dams that delivered a litter within 24 h of
each other were used in cross-fostering experiments. Acta2+/+
dams were mated with Acta2+/+ males and Acta2−/− dams were
mated with Acta2−/− males. The litters born to Acta2−/− and
+/+ dams were swapped as described (Chen and Capecchi, 1999).
In some experiments, synthetic oxytocin (Sigma, St. Louis, MO) was
injected into the appropriate mice twice daily 24 h postpartum until
weaning or an experimental endpoint. Administration of daily oxyto-
cin rescued several milk letdown phenotypes such as that observed in
mf3 null mice (Labosky et al., 1997) and oxytocin (oxt) null mice
(Nishimori et al., 1996).
Serum total protein and albumin measurements
Blood chemistry measurements were done as described (Kwon et
al., 2001) with several modiﬁcations. Blood from pups (n=10–12) of
three litters for each indicated measurement were collected and
placed in heparinized coated tubes. Serum fraction was isolated
from the clotted blood by centrifugation at 4 °C and frozen at
−80 °C. The levels of total protein and albumin were determined by
University of Texas Southwestern Mouse Metabolic Phenotyping
Core using a Vitros 950 Chemistry Analyzer (Johnson and Johnson,
Rochester, NY).
Histology and immunohistochemistry
Mammary glands were dissected and embedded in parafﬁn as de-
scribed (Seagroves et al., 1998). Immunohistochemistry was per-
formed on formalin ﬁxed specimens, subjected to an antigen
retrieval step as previously described (Katoh et al., 1997). Sections
were incubated with primary antibody for 3 h at room temperature,
washed in PBS for 20 min, and incubated with ﬂuorescent labeled
secondary antibody diluted in PBS for 1 h. Sections were washed
and mounted (Gel/Mount™ BiØmedia, Fisher Scientiﬁc, Ashville,
NC). Myoepithelial cells were ﬁxed in a 50:50 mixture of acetone
and methanol, incubated with antibodies, and immunoﬂuorescent
signals were detected using a confocal microscope (LSM 510; Carl
Zeiss, Inc, Thornwood, NY). Images were imported and arranged in
Adobe Illustrator CS2 (Adobe, San Jose, CA).
Analysis of alveolar diameters
Whole-mount preparation was done as previously described
(Robinson et al., 1998). The diameter of the duct lumen was mea-
sured using a calibrated eyepiece reticule as described (Van Nguyen
and Pollard, 2002) in sections from lactation time points. Twenty
blinded measurements were taken for each time point in 5 different
mammary glands.
TUNEL assay
Mammary glands were ﬁxed and sectioned at speciﬁc time points
and analyzed for apoptosis by terminal deoxynucleotidyl transferase
mediated dUTP nick end labeling (TUNEL) as described (Tepera et
al., 2003). The TUNEL terminal transferase was purchased from
(Roche, Mannheim, Germany) and utilized per instructions. For
each time point, 2000–4000 total cells were counted by identiﬁcation
of DAPI stained nuclei. At least three mammary glands, including
3N. Weymouth et al. / Developmental Biology 363 (2012) 1–148 ﬁelds for each gland, were examined for each time point. All count-
ing was performed in a blinded fashion in random ﬁelds.Myoepithelial cell isolation and contraction
Primary myoepithelial cell isolation was done as previously de-
scribed (Nakano et al., 2001), with minor modiﬁcations. All myoe-
pithelial cells (Acta2+/+ and −/−) used were isolated between 17
and 20 dpc. In brief, Acta2−/− mammary gland tissue tended to
ﬂoat in the initial wash steps. Therefore, this buoyant material was
washed in suspension, collected and pelleted. Isolated cells were
grown in DMEM medium (Invitrogen) plus 10% fetal bovine serum
(FBS) for 7–10 days before further experiments.
Myoepithelial cell contraction was assessed as described (Rockey
et al., 1993), with minor modiﬁcations. Brieﬂy, after solidiﬁcation of
collagen lattices, myoepithelial cells were trypsinized and layered
on top of the lattice at a density of 0.25×106 cells per well. Cells pas-
saged two or fewer times were used for contraction assays. After 24 h,
lattices were washed and serum free mediumwas added. Contraction
was induced by an exchange of serum free DMEMmedium containing
10% FBS serum. Lattices were immediately released from well walls
by gentle circumferential separation using a sterilized spatula; con-
traction was measured electronically over time. Myoepithelial cells
used in rescue experiments were infected with the Acta2 adenovirus
(Ad5 Acta2) after 3 days of culture.Immunoblotting
Mammary glands were carefully dissected to exclude skin or mus-
culature and were homogenized in a solution containing 1 ml of
10 mM Tris pH 7.5, 0.9% NaCl, and 1.5% SDS. Equal quantities of cell ly-
sates (Lowry et al., 1951) (25 μg) were separated using 4–12% Bis Tris
NuPAGE (Invitrogen) and 10% SDS PAGE gels, transferred to nitrocel-
lulose membranes, placed in blocking solution (5% donkey serum in
TBS plus 0.1% Tween). Membranes were then exposed to primary an-
tibodies followed by anti mouse secondary antibodies conjugated to
HRP (Jackson ImmunoResearch, West Grove, PA). Speciﬁc signals
were detected with an enhanced chemiluminescent (ECL) substrate
kit as per the manufacturer's instructions (Pierce SuperSignal West
Dura Extended Duration Substrate, Rockford, IL) and quantiﬁed with
a Chemigenius2 photodocumentation system (Syngene, Fredrick,
MD) and Gene Tools software (Syngene, Fredrick, MD). Loading con-
trols included blots probed for GAPDH, α-tubulin, and duplicate
Coomassie stained gels.Acta2 adenovirus
A full-lengthmouse Acta2 cDNA (encoding 377 aa, GenBank acces-
sion number: X13297) was cloned from mouse hepatic myoﬁbro-
blasts or myoepithelial cells using a PCR approach (sense-Nhe1: 5′
ACTAGCTAGCATGTGTGAAGAGGAAGACAGC; antisense-Not1: 5′
ATAGCGGCCGCTTAGAAGCATTTGCGGTGGAC). The resulting Acta2
cDNA insert was ligated into the pShuttle2 vector (Clontech Adeno-
X expression system, Mountain View, CA) and sequenced to verify
its authenticity. The Acta2 cDNA expression cassette was released by
Ceu1 and Sce1 and then inserted into pAdeno-X. Following the trans-
fection of HEK293 cells, Acta2 expression adenovirus was generated,
puriﬁed, and titered according to manufacturer's instructions (Clon-
tech Adeno-X Expression System). The Acta2 adenovirus (Ad5
Acta2) has a titer of 7.2×1010pfu/ml and the CMV empty adenovirus
(Ad 5 CMV) has a titer of 2.7×1011 pfu/ml. Myoepithelial cells were
infected with Ad5 CMV or Ad5 Acta2 at the indicated MOI (20–40)
for 24 h. Infected cells were then assayed for contraction on collagen
matrices.cDNA synthesis and real time PCR (qPCR)
Total RNA was extracted from Acta2+/+ and −/− myoepithelial
cells using Trizol (Invitrogen). Total RNA (1 μg) was reverse tran-
scribed using the High Capacity cDNA Kit (Applied Biosystems, Foster
City, CA). 50–100 ng of cDNA were used for qPCR and ampliﬁcations
were performed using the 7900 HT Fast Real Time PCR Machine
(Applied Biosystems). Cycling conditions were step 1: 50 °C for
2 min, step 2: 95 °C for 10 min, step 3: 95 °C for 15 s, step 4: 60 °C
for 1 min, cycle back 45 times to step 3. All Taqman primer probe
sets for all six actin isoforms were purchased from Applied Biosys-
tems (Assays on Demand Gene Expression, Applied Biosystems). To
ensure speciﬁcity, assays were chosen based on amplicons with the
highest degree of sequence identity to speciﬁc actin isoform
transcripts.
Taqman primer probe sets used in these experiments were as
follows:
GAPDH Assay ID #MM99999915_g1
Cytoplasmic γ-Actin (Actg1) Assay ID #MM01743531_g1
Cytoplasmic β-Actin (Actb) Assay ID #MM00607939_s1
Smooth Muscle α-Actin (Acta2) Assay ID #MM00725412_s1
Smooth Muscle γ-Actin (Actg2) Assay ID #MM00656102_m1
Cardiac α-Actin (Actc1) Assay ID #MM0477277_g1
Skeletal α-Actin (Acta1) Assay ID #MM0570060_gH
All PCR reactions included 300 nM of each primer, 200 nM probe,
and 1X TaqMan Universal PCR Master Mix (Applied Biosystems) con-
taining the passive reference ROX. The ΔΔCt method (Livak and
Schmittgen, 2001) was used to calculate relative expression levels
and normalized to an endogenous control (GAPDH). Melting curve
analysis conﬁrmed that one product was ampliﬁed. All real-time Taq-
Man PCR reactions were done in triplicate. In Fig. 8D, relative compar-
isons of Acta2+/+ to−/− isoactin transcript levels were determined
whereby Acta2+/+ levels were set to one.
Statistical analysis
Results are expressed as mean±s.e.m. Signiﬁcance was estab-
lished using the Student's t-test and analysis of variance when appro-
priate. Differences were considered signiﬁcant when pb0.05.
Results
Smooth muscle α-actin−/− dams exhibit a defective nursing phenotype
We discovered that pups nursed by Acta2−/− dams were under-
sized and died soon after birth. Further, we noted a lack of milk in the
stomachs of pups nursed by Acta2−/− dams postpartum (Fig. 1A,
upper row) compared to those pups nursed by Acta2 wild type
(+/+) dams (Fig. 1A, lower row), regardless of litter genotype. In
order to determine the growth characteristics of Acta2−/− pups,
we designed a series of matings. We measured postpartum pup
weights daily and found Acta2−/− pups nursed by Acta2−/− dams
were severely undersized and failed to gain weight compared to
Acta2+/+ pups nursed by Acta2+/+ dams (Fig. 1B). A majority
(67%, n=36/54) of Acta2−/− pups died within 16 days after parturi-
tion. Of the remaining pups, the average weight was 3.00 g (n=18)
compared to Acta2+/+ pups, which had an average weight of 6.7 g
(n=124). By 22 days postpartum, only 4 out of 54 Acta2−/− pups
nursed by Acta2−/− dams lived (average weight of 2.72 g). In con-
trast, 122 out of 124 Acta2+/+ pups nursed by Acta2+/+ dams sur-
vived (average weight of 8.33 g).
In cross fostering experiments in which four different mother pup
genotypes were examined, we reasoned that if stunted postnatal
growth were due to a defect in the offspring, pup growth would
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Fig. 1. Postnatal growth characteristics of Acta2+/+ and−/− pups. In (A), is shown a representative example of Acta2−/− pups nursed by Acta2−/− dams (upper row) and Acta2+/+
pups nursed by Acta2+/+ dams at 4 days postpartum (lower row). Note the absence of milk in the stomach of Acta2−/− pups and the presence of milk in the Acta2+/+ pups nursed by
Acta2+/+ dams (arrows point to stomachs). In (B), is shown a graphic summary of postpartum growth of Acta2+/+ and −/− mice. In addition, Acta2−/− pups nursed by Acta2−/−
damswere given oxytocin daily in an attempt to stimulate milk letdown (*pb0.05, 2–8 days; **pb0.01: (Acta2+/+pups (n=124) vs. Acta2−/− pups (n=54)) or Acta2−/− pups nursed
by Acta2−/− dams given oxytocin (n=55), 9–22 days). In (C) and (D), Acta2+/+ and−/− pups were cross fostered to dams of the opposite genotype on day one postpartum. In (C), is
shown a representative example; the three pups on the left are Acta2−/− pups cross fostered with an Acta2+/+ dam and the three pups on the right are Acta2+/+ pups cross fostered
with an Acta2−/− dam (day 13 postpartum). In (D), the weights of pups from multiple cross fostering experiments are depicted graphically (*pb0.05, day 4; **pb0.01: Acta2−/− pups
(n=62) vs. Acta2+/+ pups (n=72), 8–24 days). In (E), survival and postnatal growth at day 22 postpartum of all pups fostered is depicted graphically (***pb0.001: pups nursed by Acta2
−/− vs. Acta2+/+dams). In (F), levels of circulating proteins and serum albumin in pups nursed by Acta2+/+ or−/− dams (n=10; ** pb0.01: pups nursed by Acta2−/− dams vs. Acta2
+/+ dams).
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type was related to the nursing ability of the dam, an Acta2+/+ dam
nursing Acta2−/− pups should rescue the phenotype. In these exper-
iments, all pups were cross-fostered at one day postpartum and mon-
itored daily. Fig. 1C shows a representative cross fostering
experiment. We found that the growth curve of any pup nursed by
an Acta2−/− dam was markedly abnormal (Fig. 1D). Acta2−/−
pups rescued by cross fostering with an Acta2+/+ dam had an aver-
age weight of 9.43 g at 22 days compared to 3.03 g for Acta2+/+
pups nursed by an Acta2−/− dam (n=54 for Acta2−/− pups res-
cued by Acta2+/+ dams vs. Acta2+/+ pups nursed by Acta2−/−
dams, pb0.0001). Further, 87% (54/62) of all Acta2−/− pups cross
fostered to an Acta2+/+ dam lived more than 22 days postpartum
compared to only 12% (10/79) of Acta2+/+ pups cross fostered to
an Acta2−/− dam (n=79, pb0.0001, Fig. 1E). These ﬁndings lead
us to conclude that Acta2−/− dams are unable to nurse their pups.
To conﬁrm further that pups nursed by Acta2−/− dams are malnour-
ished due to a nursing defect, we evaluated total circulating protein
and serum albumin levels in pups (n=10, 5 days postpartum) nursed
by Acta2+/+ and −/− dams. There is a signiﬁcant decrease in total
protein (Acta2+/+ pup levels 5.22 g/dl vs. Acta2−/− pup levels
2.82 g/dl) and serum albumin (Acta2+/+ pups levels 2.42 g/dl vs.
Acta2−/− pup levels 1.33 g/dl). These indicators of abnormal blood
chemistry suggest that pups nursed by Acta2−/− dams are severely
malnourished (n=8, pb0.0001, Fig. 1F).
We next queried whether oxytocin mediated maternal abnormal-
ities could be involved in the observed phenotype. The rationale for
this is that oxytocin is known to play a role in nursing (Takayanagi
et al., 2005) and maternal nurturing behaviors (i.e., pup retrieval,
nest building, pup licking, and grooming (Insel and Young, 2001;Winslow and Insel, 2002)), and defects in oxytocin release or signal-
ing often resulting in a phenotype similar to that observed in Fig. 1A
(Fahrbach et al., 1985; Insel and Harbaugh, 1989; Pedersen et al.,
1985). Oxytocin (600 mU/kg) injected twice daily into Acta2−/−
dams from day one postpartum until 22 days postpartum failed to
alter the postnatal growth of pups (Fig. 1B, closed circles). Further,
oxytocin had no effect on the normal maternal behavior we observed
in Acta2−/− dams. Finally, Acta2−/− pups appeared to develop nor-
mally when nursed by Acta2+/+ and +/− dams (Fig. 1D). Except for
a mild delay or failure in parturition occurring in 10% of Acta2 null
dams, there were no other gross defects besides the described nurs-
ing defect in Acta2 null dams.
Pups nursed by smooth muscle α-actin−/− dams die due to
malnutrition
Given the absence of milk and the rescue of postnatal growth in
Acta2−/− pups by cross fostering with an Acta2+/+ dam, we pre-
dicted pups nursed by an Acta2 null dam were unable to thrive due
to malnutrition. Several potential lactation defects might account for
the results in Fig. 1 (Palmer et al., 2006). Thus, we sought to detect his-
tological signs of starvation in pups nursed by Acta2 dams. Midthorax
sections of nursed pups 4 days postpartum from each of the different
mother pup combinations revealed smaller midthorax diameters in
pups nursed by Acta2−/− dams (Figs. 2A–D), reduced amounts of fat
between the outer dermis and the musculature (Figs. 2E–H), as well
as the absence of lipid droplets in brown fat regions (Figs. 2I–L). Of
note, the outer dermis appears to be thicker in Acta2−/− pups nursed
by Acta2+/+ dams (Fig. 2F). As a control, an Acta2+/+ pup nursed by
an Acta2+/+ dam, which did not nurse for 48 h, displayed a complete
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Fig. 2. Severe malnourishment in pups nursed by Acta2−/− dams. Each column contains three pictures from a speciﬁc cross fostering pair as indicated on top of each column. In
(A–D), pups of the speciﬁed genotype and cross fostering dam were sacriﬁced at day 4 postpartum; midthorax sections are shown (scale bar=1 mm). In (E–H), are representative
views of the outer dermis (scale bar=200 μm) and in (I–L) are representative images of brown adipose regions as indicated (scale bar=50 μm). Note the smaller midthorax di-
ameter (C and D), the reduced layer of adipose fat between the outer dermis and the musculature (G and H) as well as the absence of lipid droplets (K and L) within regions of
brown adipose tissue of pups nursed by Acta2−/− dams.
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cogen stores in the skeletal muscle (N. Weymouth, unpublished). The
data indicate that the cause for severe malnourishment of pups+/+
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during gestation and lactation
We considered several possible mechanistic explanations for the
inability of newborn pups to develop during lactation. For example,
pups could be receiving milk that is poor in nutritional value or
they were not getting enough milk during lactation. Defects in lacta-
tion could arise from impaired alveolar differentiation, deﬁciencies in
milk composition (Zoubiane et al., 2004), secretion (Stinnakre et al.,
1994), or abnormalities in milk letdown (Palmer et al., 2006).
Mouse milk is composed of 12% protein, 30% lipid, and 5% lactose.
The major protein components of milk consist of β-casein, whey acid-
ic protein, immunoglobulin A, and α-lactalbumin (Anderson et al.,
2007). To address the possibility that Acta2−/− dams had a defect
in milk composition or secretion, we analyzed the expression of
milk proteins by immunoblotting and we found no abnormalities in
milk protein composition in Acta2−/− mammary glands.
We next considered whether defects in alveolar differentiation, as
has been previously described (Liu et al., 1997), could account for the
observed nursing phenotype. Thus, we explored the formation of
lobuloalveolar structures capable of producing milk in Acta2−/−
mice. Histological and whole mount analysis of Acta2+/+ and −/−
mammary glands at various stages of pregnancy revealed that during
early to mid pregnancy, mammary glands appeared normal (Figs. 3A–
C, E–G). There were no differences in ductal elongation and formation
of lobuloalevolar structures. However, during the late stages of gesta-
tion (18–20 days post-coitus (dpc)), we observed alveolar distension
of mammary glands from Acta2−/−mice (Figs. 3D,H). This difference
was even more pronounced in whole mounts, where mammary
glands from Acta2−/−mice appeared to have a greater alveolar den-
sity (Figs. 3 I–L). Mammary glands from Acta2−/− mice (Fig. 3H)
were isolated 20 days after a copulation plug was noted. A potential
problem with parturition in Acta2−/− dams might explain the alve-
olar distension and milk stasis noted in (Fig. 3H). The data suggest
that the deﬁciency of Acta2 does not affect ductal morphogenesis or
alveolar differentiation.
We noted that postpartummammary glands from Acta2−/−mice
were fully engorged with milk, raising the possibility that milk stasis
and precocious involution occur even in the presence of a normal
suckling stimulus. This led us to postulate that the observed pheno-
type in Acta2−/− mice is due to an abnormality in milk letdown.
We also considered whether the neuroendocrine milk reﬂex arc, me-
diated by oxytocin, and essential for milk letdown could be abnormal
in Acta2−/− mice (Palmer et al., 2006). Proper sucking and milk re-
moval during lactation are needed for the maintenance of lactation
(Wagner et al., 1997). Further, oxytocin-mediated contraction of
myoepithelial cells (Gimpl and Fahrenholz, 2001) also appears to be
important (e.g., ablation of oxytocin or the oxytocin receptor leads
to a milk letdown phenotype with premature involution in null mam-
mary glands (Nishimori et al., 1996; Takayanagi et al., 2005)). Nota-
bly, involution, occurring normally after lactation and triggered by
pup weaning, is characterized by two distinct phases: an early
phase of milk engorgement, followed by epithelial apoptosis, and
then a tissue remodeling phase characterized by an increased expres-
sion of proteinases (Lund et al., 1996). Acta2−/− mammary glands
exhibited signs of milk stasis and involution shortly after parturition
(Figs. 4 B, D, F, H, J, and L). Acta2+/+ mammary glands displayed aFig. 4. Mammary glands of Acta2−/− mice exhibit milk stasis, alveolar distension, and pre
indicated times during lactation (H&E, scale bar=50 μm). Indicated days precede either d
same mammary tissue shown in (E) and (F), respectively (H&E, scale bar=200 μm). In
Acta2+/+ dam (K) and Acta2−/− dam (L) (scale bar=1 mm). In (M), the alveolar diam
data depicted graphically at the indicated times after parturition (n=5 ﬁelds and 6 mice
(N), ducts were counted as described in the Materials and methods and the average num
Acta2+/+ dams vs. Acta2−/− dams at all time points).typical acinar like morphology of milk producing epithelial cells lin-
ing the ducts, which in turn are surrounded by a layer of contractile
myoepithelial cells. These ducts are surrounded by an extensive
framework of connective tissue, known as the stroma, consisting of
extracellular matrix, adipose tissue, lymphatic tissues, and ﬁbroblasts,
which often lie in the intervening vasculature of the gland. During
lactation in Acta2+/+ dams, there were no signiﬁcant histological
changes until weaning (Figs. 4A, C, E, G, I, and K). However,
Acta2−/− dams exhibited morphological changes during lactation,
consistent with premature involution (Figs. 4B, D, F, H, and J). Of
note, mammary ducts are generally surrounded by extensive connec-
tive tissue. However, this connective tissue stroma was much less ap-
parent surrounding the alveoli in the normal lactating gland as shown
in Fig. 4, panels A, C, E, G, and I. The adipose stroma has reappeared in
the sections from Acta2−/− mice, characteristic of dams with lacta-
tion failure where adipose lipid is not mobilized for milk synthesis.
Thus, histological changes, shown in Fig. 4, panels D, F, and H, were
apparent. During early lactation (0–6 days postpartum), there were
signs that the ﬁrst phase of involution had already occurred. There
was extensive distension of the alveoli due to milk engorgement
(Fig. 4M). Furthermore, the surrounding stroma had been dramatical-
ly altered or even remodeled at these early stages. At both 10 and
16 days of lactation, there were a large number of apoptotic cells in
the lumen of Acta2−/− glands (Figs. 4F and J) and a collapse of alve-
olar structures (Fig. 4H). Throughout lactation, mammary glands
from Acta2−/− mice had a greater average alveolar diameter
(Fig. 4M) and a decrease in the number of alveoli (Fig. 4N) than did
those from Acta2+/+ mice.
Mammary glands from smooth muscle α-actin−/− mice exhibit
precocious involution highlighted by myoepithelial cell apoptosis
Given that lactating mammary glands from Acta2−/− mice dis-
played signs of precocious involution and apoptosis, we measured
the number of apoptotic cells at various stages of lactation. In
Acta2+/+ mice, TUNEL positive cells were not detected in early or
mid-stage lactation (Figs. 5A–D). In contrast to Acta2−/− mice,
TUNEL analysis revealed signiﬁcantly more apoptotic cells lining
ducts and cells sloughed into the lumen (Figs. 5E–H, Fig. S1). Quanti-
tative changes in the number of apoptotic cells in Acta2−/− mice
were quite remarkable during lactation (Fig. 5I). These data indicate
that mammary glands from smooth muscle α-actin−/−mice exhibit
precocious involution highlighted by apoptosis.
In several samples from Acta2−/− mice, we observed the pres-
ence of apoptotic cells on the outside of the ducts, especially in late
gestation and shortly after parturition (Figs. 5E–G, and K, Fig. S2, ar-
rows in Figs. 5E and K). This ﬁnding led us to query whether there
may be abnormalities in myoepithelial cells, which are found sur-
rounding epithelial cell acini, during lactation. To test this possibility,
we examined myoepithelial and epithelial cells at time points during
gestation and postpartum. We used an anti-keratin 14 antibody to
label myoepithelial cells and an anti-keratin 8 antibody to label epi-
thelial cells. Additionally, in Acta2+/+ mice, we labeled myoepithe-
lial cells with an anti-Acta2 antibody. In mammary glands from
Acta2+/+ mice, branched hollow ducts of epithelial cells were sur-
rounded by keratin 14 and smooth muscle α-actin positive myoe-
pithelial cells (Figs. 6A–D; Note — Fig. 6 contains only mergedcocious involution during lactation. In (A–H), mammary glands were harvested at the
ays post-coitus (dpc) or lactation (L). (I and J) are higher magniﬁcation views of the
(K and L), are images of representative mammary glands 12 h after parturition: an
eter from multiple sections was quantiﬁed as in the Materials and methods and the
per time point; **pb0.01: Acta2+/+ dams vs. Acta2−/− dams for all time points). In
ber of ducts per ﬁeld is depicted (n=5 ﬁelds and 6 mice per time point; ***pb0.001
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Fig. 5. Enhanced apoptosis in Acta2−/−mammary glands. In (A–H), Acta2+/+ and−/−mammary glands were harvested at the indicated time points. Tissues were subjected to
TUNEL as in the Materials and methods. Merged images of DAPI stained nuclei and TUNEL positive cells are shown (DAPI/blue, TUNEL positive cells/pink, scale bar=50 μm). Arrows
point to apoptotic cells which lie outside of ducts, surrounding the acini, during late gestation. Indicated days precede either days post-coitus (dpc) or lactation (L). In (I), the ratio of
TUNEL positive per DAPI positive cells, per ﬁeld, are depicted (*pb0.05 Acta2+/+ dams vs. Acta2−/− dams at 18 dpc; **pb0.01 Acta2+/+ dams vs. Acta2−/− dams at 4 L;
***pb0.001 Acta2+/+ dams vs. Acta2−/− dams at 6 L and 10 L; n=6 mice per group and 10 random ﬁelds per mouse) In (J and K), are shown higher magniﬁcation images of
A and E respectively (J — Acta2+/+, K — Acta2−/−, scale bar=100 μm).
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Figs. S2–S3 for complete immunoﬂuorescence labeling data), which
have been described as basket-like cells that surround the acini
(Franke et al., 1980). Interestingly, mammary glands from
Acta2−/− mice appeared to contain fewer myoepithelial cells
expressing keratin 14 (Figs. 6E–I, Fig. S2–3) as well as other myoe-
pithelial or smooth muscle markers (such as keratin 5, smooth mus-
cle calponin, GFAP, vimentin, smooth myosin heavy chain, and
P-cadherin; data not shown) compared to Acta2+/+ mice. The de-
crease expression in myoepithelial speciﬁc markers, such as keratin
14, in Acta2−/− mammary glands (Figs. 6E–I, Fig. S2–3, Fig. S5) and
the quantitative changes in the number of apoptotic cells in
Acta2−/− mammary glands (Fig. 5I) suggest a reduction of myoe-
pithelial cells in Acta2−/−mammary glands at all stages of gestation
and lactation as well as in the virgin state.
Isolated myoepithelial cells express smooth muscle and myoepithelial
speciﬁc markers and contract
On the basis of our ﬁndings and the fact that Acta2may be impor-
tant for cellular contraction in vivo, we determined whether Acta2 is
required for myoepithelial cell contraction. First, we conﬁrmed the
purity of isolated cells (Figs. 7A–P). We examined the following pro-
teins in primary myoepithelial cells: SM22α (Figs. 7B and D), Acta2(Figs. 7C, D, G, H, K, and L), keratin 14 (Figs. 7F, H, J, and L), keratin
5 (Fig. S4), vimentin (Fig. S4), desmin (Fig. S4), and smooth muscle
calponin (Fig. S4). Interestingly, SM22α, a calponin family actin bind-
ing protein, and Acta2, were co-localized along stress ﬁbers. Interme-
diate ﬁlaments were identiﬁed in a delicate network of threadlike
structures surrounding the nucleus and extending into the cytoplasm
(Fig. S4). Also, epithelial PtK2 control cells were immunolabeled to
detect keratin 8, an epithelial intermediate ﬁlament (Fig. 7N and P,
Fig. S4); this was identiﬁed in only 2% of cells isolated suggesting
minimal contamination by epithelial cells. In order to assay the con-
tractile properties of myoepithelial cells, we needed to conﬁrm that
the only change in contractile proteins concerns Acta2 and not
changes in myosin levels. Using Western blot analysis, non-muscle
and smooth myosin heavy chains are expressed in myoepithelial
cells and levels do not change in null cells. Skeletal muscle myosin
was not identiﬁed in myoepithelial cells. Collectively, these data indi-
cate the isolation of a homogenous population of contractile myoe-
pithelial cells (Fig. S4).
Finally, we tested the hypothesis that Acta2 is required for myoe-
pithelial cell contraction by measuring contraction of isolated
Acta2+/+ and −/− cells using a collagen lattice system. Initially,
we assessed contraction using silicone rubber substrates (Harris et
al., 1980); however, the preparation of uniform substrates was prob-
lematic for quantitative measurements, and this led us to utilize
A B C D
E F H I
Virgin
+/+
-/-
12.5 dpc 18.5 dpc 4.5L
Fig. 6.Mammary myoepithelial cell numbers in Acta2−/− dams are reduced during gestation and lactation. Mammary gland tissue sections from Acta2+/+ and−/− dams were
immunolabeled with anti-cytokeratin 14 (Alexa Fluor 488/green), anti-Acta2 (Cy3/red), and anti-cytokeratin 8 (Cy5/pink) antibodies as in the Methods. In (A–D), are shown rep-
resentative merged images of stained Acta2+/+ mammary glands at the indicated time points (scale bar=20 μm). In (E–I), are shown representative merged images of stained
Acta2−/− mammary glands at the indicated time points (scale bar=20 μm). Figures S2 and S3 contain a complete representation of individual staining: (cytokeratin 14
(green), Acta2 (red), and cytokeratin 8 (pink)). Indicated times are symbolized: the days postpartum proceed the letter “L” which stands for lactation. Abbreviation: dpc = days
post-coitus.
9N. Weymouth et al. / Developmental Biology 363 (2012) 1–14collagen matrices, which appear to be more physiological substrates
than polyacrylamide substrates and moreover allow the precise
quantiﬁcation of cellular contraction (Miron-Mendoza et al., 2008).
We found that Acta2+/+ myoepithelial cells were signiﬁcantly
more contractile than Acta2−/− cells were (Fig. 7Q) at all time points
after the initiation of contraction.
In order to explore at a molecular level the role of smooth muscle
α-actin, we expressed Acta2 in isolated Acta2 null cells using an ade-
noviral construct as described in the Materials and methods. Smooth
muscle α-actin was highly expressed when Acta2−/− cells were
infected at a MOI of 10–80 (Fig. S4). Further, Acta2 was found in
actin stress ﬁbers at the same MOIs. Forced expression of Acta2 in
Acta2−/− cells rescued contraction at MOI 20 or 40 (Fig. 7Q, Fig. S4).Expression of actin isoforms in smooth muscle α-actin−/− mammary
glands and myoepithelial cells
Given previous data suggesting redundancy in actin function, we
considered the possibility that actin isoforms could be differentially
regulated in response to the loss of Acta2. Therefore, we investigated
expression proﬁles of different actin isoforms (Figs. 8A–C) in
Acta2+/+ and −/− mammary gland tissues at various stages of de-
velopment. Acta2 expression was upregulated between 0 and
10 days of gestation (Fig. 8A) (the increase in Acta2 expression
noted in Fig. 8A probably represents an increasing proportion of
myoepithelial cells in the whole gland). There were no noticeable
gestational changes in total actin using the C4 monoclonal antibody,
which recognizes all six actin isoforms (Fig. 8B). Quantitative analysis
revealed no statistically signiﬁcant differences in total actin levels
after multiple samples were analyzed (Fig. 8B lower graph) between
Acta2+/+ and −/− tissues. Cytoplasmic β-actin levels remained
unchanged and no compensating expression was noted (Fig. 8C). Col-
lectively, these results demonstrate no compensatory response of
other actins due to the loss of Acta2 expression in mammary gland
tissues.We next determined which isoactins were expressed in myoe-
pithelial cells and whether actin isoform expression changed in
Acta2−/− cells. Speciﬁcally, we assessed both transcript and protein
levels for all six actin isoforms (Figs. 8D and E). As expected, cytoplas-
mic actins (β/γ) mRNAs were present in myoepithelial cells, but in-
terestingly, there were no quantitative changes noted in Acta2−/−
cells. The levels of other muscle actins mRNAs were not signiﬁcantly
different than background levels but presented for completeness.
Acta2mRNA was abundantly expressed in Acta2+/+ cells but absent
in Acta2−/− cells (Fig. 8D). Actin isoform protein levels were mea-
sured via immunoblotting using ﬁve different monoclonal antibodies
speciﬁc for different actin isoforms as indicated on the right hand side
of both panels (Fig. 8E). First, we tested the speciﬁcity of each anti-
body using puriﬁed actins from different tissues (Fig. 8E, left panel,
1 μg/lane). Smooth muscle α and γ-actin were abundant in gizzard
and not found in platelets (Fig. 8E, upper left panels). Cytoplasmic ac-
tins (β/γ) were abundant in platelets and surprisingly quite low in
heart (Fig. 8E, middle left panels). Using the 5C5 monoclonal anti-
body, which recognizes both cardiac and skeletal α-actins, either or
both muscle actins were found in skeletal and cardiac muscles but
not expressed in platelets (Fig. 8E, lower left panels). Next, we
determined the actin isoform composition in myoepithelial cells and
whether there were changes in actin isoform levels due to the loss
of Acta2 expression (Fig. 8E right panel; Fig. S5 K–Q for
densitometry quantiﬁcation (n=5–8)). As expected, Acta2 was
abundantly expressed in Acta2+/+ cells but not in Acta2−/− cells
(Fig. 8E right panel). Smooth muscle γ-actin was not present in
Acta2+/+ or −/− cells (Fig. 8E, right panel). Of note, smooth muscle
γ-actin, was found in gizzard but was not present in platelets (Fig. 8E
upper left panel) using the same anti-smooth muscle γ-actin monoclo-
nal antibody (B4) used for analysis of myoepithelial lysates (Fig. 8E
right panel). Further, cardiac and skeletal α-actins were not present
in Acta2+/+ or −/− cells (Fig. 8E, right panel). As expected, both
cytoplasmic actins (γ/β) were present in Acta2+/+ and −/− cells
(Fig. 8E, right panel), but no quantitative changes in the cytoplasmic
actins (β/γ) were found in Acta2 null cells (Fig. S5, O–P). Total actin
+/+
A B C D
E F G H
I J K L
M N
O P
Q
0
20
40
60
80
100
0 60 120 180 240
La
tti
ce
 C
on
tra
ct
io
n
 
(%
 in
itia
l la
ttic
e a
rea
)
Time (min)
+/+
-/-
1020
+/+
-/-
***
******
***
***
-/- Ad5 CMV
-/- Ad5 Acta2 MOI 20
-/-Ad5Acta2 MOI 40
Fig. 7. Phenotypic characterization and rescue of impaired myoepithelial contractility in Acta2−/− cells. Myoepithelial cells from Acta2+/+ and−/− dams were isolated as in the
Materials and methods. In (A–L), after two days in culture, myoepithelial cells were subjected to immunolabeling to detect the following: sm22α (B, Alexa Fluor 488/green), cyto-
keratin 14 (F and J; Alexa Fluor 488/green), and smooth muscle α-actin (C, G, and K; Cy3/red). In (D, H, and L) are shown merged images of sm22α or cytokeratin 14 and smooth
muscle α-actin immunolabeling (scale bar=50 μm). Control PtK2 epithelial cells were immunolabeled with Acta2 (M, Cy3/red) or cytokeratin 8 (N, Cy5/pink). Control smooth
muscle A7r5 cells in (O) were dual immunolabeled with smooth muscle α-actin (Cy3/red) and cytokeratin 14 (Alexa Fluor 488/green). In (P), A7r5 cells were dual immunolabeled
with cytokeratin 8 (Cy5/pink) and cytokeratin 14 (Alexa Fluor 488/green) (scale bar=20 μm). Merged images for (O and P) are shown. In (A, E, I, D, H, L, and M-P), BOPRO1/blue
was used to label nuclei. In (Q), isolated myoepithelial cells were subjected to collagen lattice contraction assays as described in Materials and methods. In some experiments, iso-
lated Acta2−/−myoepithelial cells were infected with an adenovirus expressing smooth muscle α-actin (Ad5 Acta2) at the indicted MOIs as in Materials and methods (2nd: n=4
for each time point, ***pb0.001 for Ad5 Acta2 treated cells (MOI 20 or 40) vs. Acta2−/− cells; 1st: n=6 for each time point, ***pb0.001 for Acta2+/+ cells vs. Acta2−/− cells).
10 N. Weymouth et al. / Developmental Biology 363 (2012) 1–14protein levels were decreased in Acta2−/− cells (Fig. S5 Q, Fig. 8E,
right panel). In aggregate, these results led us to conclude that
myoepithelial cells contain the following three actin isoforms:cytoplasmic β-actin, cytoplasmic γ-actin, and smooth muscle α-actin.
Further, there was no compensatory upregulation of any actin isoform
in Acta2−/− cells.
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Fig. 8. Actin isoform composition in Acta2−/−mammary glands and isolated myoepithelial cells. In (A–C), Acta2+/+ and−/−mammary glands were harvested at the indicated
times and lysates were subjected to immunoblotting as in Materials and methods. In (A), is shown a representative immunoblot (n=6) of Acta2 expression at different dpc. In
(B), is shown a representative immunoblot of total actin (n=6) levels at the indicated dpc. In (C), is shown a representative immunoblot of β-actin expression (upper panel,
n=4) and total actin expression (lower panel, n=4). For (A–C), data were scanned, quantiﬁed, and depicted graphically below each immunoblot as in Materials and methods
(*pb0.05 for Acta2+/+ vs. Acta2−/− tissues). In (D), mRNA levels of all six actin isoforms were measured in myoepithelial cells by qPCR using isoform speciﬁc probes. Expression
levels were normalized to GAPDH and calculated by the ΔΔCt method. Ratios of fold changes are presented graphically where Acta2+/+ levels were set arbitrarily at 1 (n=10,
**pb0.001 for Acta2+/+ vs. Acta2−/− transcript). In (E), actin isoform protein levels were measured in myoepithelial cells by immunoblotting with actin isoform speciﬁc mono-
clonal antibodies (n=5–10). In the left panel, puriﬁed actins (1 μg per lane) from the indicated tissues were used to test the speciﬁcity of each actin isoform antibody (n=5). In the
right panel, lysates of Acta2+/+ and Acta2−/−myoepithelial cells were subjected to immunoblotting to detect speciﬁc actin isoforms (n=10). Blots were scanned, quantiﬁed, and
presented graphically in Fig. S5. α-tubulin and coomassie stained gel serve as loading controls. Abbreviation: dpc = days post-coitus.
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We have discovered a remarkable mammary gland phenotype in
Acta2 deﬁcient mice. Acta2−/−mammary glands have normal levels
of cytoplasmic (β/γ) actins (Actb, Actg1, respectively) and there is no
compensatory change in total actin (Figs. 8A–C), yet milk ejection
during nursing was defective (Fig. 1). This was presumably due to
an inability of myoepithelial cells to contract (Fig. 7Q). Because
Acta2−/− myoepithelial cells are hypocontractile, mammary glands
exhibit postpartummilk stasis, alveolar dilation, and precocious invo-
lution (Fig. 4), which ultimately leads to the starvation of nursing
pups (Fig. 2). We provide a comprehensive analysis of Acta2's role
in mammary gland development, which indicates signiﬁcant struc-
tural changes during lactation, and precocious involution in Acta2
null glands due to myoepithelial dysfunction (Figs. 3–6). Also, we
have shown that myoepithelial cells contain only three actin iso-
forms: cytoplasmic γ-actin (Actg1), cytoplasmic β-actin (Actb), and
Acta2. Most importantly, smooth muscle γ-actin (Actg2) is not pre-
sent in myoepithelial cells nor is there any compensatory upregula-
tion of actin isoform levels in Acta2−/− cells (Figs. 8D–E). Acta2
serves a speciﬁc function in myoepithelial contraction without com-
pensation by a similar actin isoform, (i.e., such as Actg2). Thus, Acta2
is required for the maintenance of lactation.Our ﬁndings address a fundamental question in actin biology as it
relates to the issue of actin isoform speciﬁcity. Molecular genetic
studies of actin isoform mutants in model organisms and mouse
actin knockouts have generated valuable data, which might help ex-
plain the functional signiﬁcance of amino acid differences among iso-
actins (Hennessey et al., 1993; Kato-Minoura et al., 1997; Mahaffey et
al., 1985; Perrin and Ervasti, 2010; Willis et al., 2006). On one hand, it
has been proposed that minor amino acid differences in actin iso-
forms are functionally not important and that multiple actin genes
may actually only reﬂect differences in total actin requirements for
a particular cell type (Nowak et al., 2009; Wagner et al., 2002). S. cer-
evisiae has one actin isoform (ACT1) and it is essential for viability.
Despite only 90% identity, human Actb can substitute for mutants of
ACT1 without any loss of viability (Karlsson et al., 1991). Data from
several actin knockouts including Actb, Acta1 (skeletal α-actin),
Actc1 (cardiac α-actin), and Acta2 null mice have revealed a paucity
of phenotypes and compensatory expression of closely identical iso-
actins which would suggest that actin isoforms are not tied to a spe-
ciﬁc function (Crawford et al., 2002; Kumar et al., 1997; Perrin and
Ervasti, 2010; Schildmeyer et al., 2000; Shawlot et al., 1998). Recent-
ly, it was shown that Actc1 expression is sufﬁcient to replace skeletal
muscle functional deﬁciencies in Acta1 null mice (Nowak et al., 2009).
These studies conclude by suggesting these actin isoforms are
12 N. Weymouth et al. / Developmental Biology 363 (2012) 1–14functionally equivalent and thus redundant. On the other hand, it is
possible that small amino acid differences are functionally important.
For example, the Actc1 phenotype could only be partially rescued
with cardiac expression of Actg2 (Kumar et al., 1997). Likewise, over-
expression of Actg1 is unable to rescue the postnatal lethality of Acta1
deﬁcient mice even when total actin was restored to normal levels
(Jaeger et al., 2009). In a conditional allele for Actg1 in skeletal muscle,
mice exhibited overt symptoms of skeletal myopathy: decrease mo-
bility, limb weakness, and joint contractures. This phenotype suggests
that Actg1 serves a speciﬁc function even in skeletal myocytes
(Sonnemann et al., 2006). Previously, it has been shown that Acta2
null mice have a vascular phenotype in which null mice have a de-
creased in blood pressure and an increase in blood ﬂow, yet compen-
satory expression of isoactins was noted in Acta2 null aortas
(Schildmeyer et al., 2000). Collectively, these studies support the no-
tion actin isoactins can mediate speciﬁc cellular processes and point
out the inherent difﬁculties in proving that an isoactin is required
for a speciﬁc function.
We performed a strict test of our hypothesis that Acta2 speciﬁcally
mediates myoepithelial contraction by exogenous expression of Acta2
in Acta2 deﬁcient myoepithelial cells, which rescued contraction
(Fig. 7Q). We considered an alternative approach — transgenic ex-
pression of Acta2 speciﬁcally in null mammary glands using a myoe-
pithelial speciﬁc promoter or by the exogenous expression of Acta2
in isolated null myoepithelial cells. We chose the latter approach be-
cause it allows us to rule out any potential non-autonomous effects
(e.g. vascular defects in Acta2 mice (Schildmeyer et al., 2000) or po-
tential problems associated with oxytocin mediated milk secretion
(Lollivier et al., 2006)) which might play a role in the observed phe-
notype. This cell based approach would preclude us from extensive
mammary gland transplantation experiments or the creation of an-
other transgenic mouse to demonstrate that Acta2 is speciﬁcally re-
quired for myoepithelial contraction and the maintenance of
lactation. Clearly, we have utilized this approach to measure and res-
cue compromised myoepithelial contraction in null cells (Fig. 7Q and
S4).
In order to draw a distinction between whether a defect in myoe-
pithelial total actin levels or Acta2 functional speciﬁcity is responsible
for the observed phenotype, we speciﬁcally evaluated compensatory
expression of actin isoforms in Acta2 null cells. It was previously dem-
onstrated that Acta2−/− aortas had an increase in Acta1 expression,
which led to the suggestion that Acta1 might substitute for Acta2's
functionality (Schildmeyer et al., 2000). Interestingly, transgenic ap-
proaches have been used in an attempt to rescue phenotypes ob-
served in mice deﬁcient for Acta1 (Jaeger et al., 2009; Nowak et al.,
2009) and Actc1 (Kumar et al., 1997) to address the question of
actin isoform speciﬁcity. The upregulation in expression of another
isoactin in response to the loss of Acta2 in myoepithelial cells would
suggest that another isoactin contributes to myoepithelial contractil-
ity. In Fig. 8, we show that there was no upregulation in expression of
another isoactin in Acta2 null cells, suggesting that myoepithelial con-
tractility is mediated by Acta2. Cytoplasmic β-actin (Actb)−/− mice
have an embryonic lethal phenotype; however, Actb+/− dams are
able to nurse their litters normally (Shawlot et al., 1998). Litters
nursed by Actg1−/− dams exhibited normal postnatal growth
(Belyantseva et al., 2009). These studies argue against the functional
contribution of cytoplasmic (β/γ) actins in this phenotype. Thus,
our data conﬁrms that Acta2, without functional contribution by cyto-
plasmic (β/γ) actins, is essential for myoepithelial contraction.
We speculate that there may be a requirement for a particular
composition of actin in myoepithelial cells to mediate contractility
and the integrity of the actin cytoskeleton needed for cell survival. It
is possible that a reduction in total actin levels due to the deletion
of Acta2 causes cell speciﬁc apoptosis given the composition of isoac-
tins in a given cell type. Our data emphasize that Acta2 is highly
expressed in myoepithelial cells; in this case, the ratio of Acta2 toother actin isoforms may be critical and in Acta2's absence, the cell
is likely unable to compensate. This is consistent with previous obser-
vations. Pharmacological disruption of actin dynamics (Celeste
Morley et al., 2003; Gourlay and Ayscough, 2005; Gourlay et al.,
2004; Posey and Bierer, 1999; Zhang et al., 1997), ablation of Actc1
in hearts (Abdelwahid et al., 2004), or depletion of cytoplasmic actins
(β/γ) isoforms triggers apoptosis (Dugina et al., 2009; Harborth et al.,
2001). It is possible that cell speciﬁc apoptosis contributes to an ob-
served phenotype in mice carrying a null allele for an actin isoform.
Given the increase in apoptosis found during lactation in Acta2 null
mammary glands (Fig. 5) and the possible loss of myoepithelial cells
(Fig. 6), we have shown that apoptosis most likely contributes to
the observations of milk stasis and precocious involution (Fig. 4).
We have shown that there are signiﬁcant structural and develop-
mental changes in Acta2−/− mammary glands, which are indicative
of milk stasis and precocious involution (Figs. 4–6). Given that myoe-
pithelial contractility is compromised, involution occurs shortly after
parturition within 2–4 days postpartum. Recently, a descriptive ac-
count of Acta2's role in myoepithelial contractility reported no struc-
tural changes in Acta2 null glands and no developmental
abnormalities due to Acta2's absence (Haaksma et al., 2011). These
conclusions are not consistent with both previous observations (Li
et al., 1997; Palmer et al., 2006;Wagner et al., 1997) and the data pre-
sented here (Figs. 4–6). Here, we have provided a complete histolog-
ical and immunoﬂuorescence analysis of Acta2's role in postpartum
development of the mammary gland at multiple time points during
lactation; as shown in Figs. 4–6, there are multiple signs that preco-
cious involution has occurred shortly after parturition. Speciﬁcally,
connective tissue stroma is signiﬁcantly less prevalent surrounding
the alveoli in Acta2+/+ lactating glands (Figs. 4 A, C, E, G, and I),
whereas the adipose stroma has reappeared in the sections of Acta2
null glands (Figs. 4 A B, D, F, H, and J), characteristic of dams with lac-
tation failure where the adipose lipid is not mobilized for milk syn-
thesis, even at 2 days postpartum. Further, previous work has
shown that disruption of the neuroendocrine reﬂex arc by litter re-
moval (Wilde et al., 1999), teat sealing (Li et al., 1997), ablation of
oxytocin (Li et al., 1997; Wagner et al., 1997) or the oxytocin receptor
(Takayanagi et al., 2005), leads to build-up of milk in the mammary
gland triggering involution within 24–48 h postpartum, fundamen-
tally similar to the morphological phenotype we have reported.
Thus, it appears that milk ejection and milk removal facilitated by
myoepithelial contraction is needed for normal postpartum develop-
ment of the mammary gland (Bruckmaier and Wellnitz, 2008; Wilde
et al., 1999).
Mechanistically, there appear to be two contributing factors for
the disruption of lactation in Acta2 null mammary glands. First, we
have shown that Acta2 appears to mediate myoepithelial contraction
in an isoform speciﬁc manner and secondly, we have demonstrated a
profound decrease in the number of myoepithelial cells in lactating
Acta2 null glands. These two features combine to cause a severe
milk stasis phenotype that includes increased apoptosis and preco-
cious involution in Acta2 null glands shortly after parturition, which
inhibits the ability of nursing pups to thrive. Thus, we conclude that
Acta2, which differs little in molecular structure from other isoactins,
has a speciﬁc function in the mammary myoepithelium and that sub-
tle amino acid differences in actin isoforms are functionally
important.
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